Strategizing Talquetamab Use In Relapsed/Refractory Multiple Myeloma: Balancing Efficacy, Infection Control, and Next-Line Therapy
Panelists discuss how a patient who is neutropenic is given supportive care with GCSF, as do patients who have prolonged neutropenia, then that patient will be on antibiotic and antifungal prophylaxis.
Video content above is prompted by the following:
- Given the patient’s history of frequent infections, how would you balance talquetamab’s efficacy with the need for infection control, and what supportive measures might you prioritize?
- How would you approach treatment sequencing if the patient progresses on talquetamab, and what criteria would you use to determine the next line of therapy?
Recent Videos
Related Content
